vTv Therapeutics (VTVT) Asset Utilization Ratio (2015 - 2026)
vTv Therapeutics (VTVT) reported Asset Utilization Ratio of 0.39 for Q1 2026, up 80618.2% on a YoY basis from N/an in Q1 2025, and up 144520.54% sequentially from 0.0 in Q3 2025.
vTv Therapeutics (VTVT) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
vTv Therapeutics (VTVT) has 12 years of Asset Utilization Ratio data on file, last reported at 0.39 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio rose 80618.2% year-over-year to 0.39; the trailing twelve-month figure through Mar 2026 stood at 0.39 (up 80618.2% YoY), and the FY2024 full-year result was 0.04, changed N/A from the prior year.
- Asset Utilization Ratio grew to 0.39 in Q1 2026, from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.39 in Q1 2026 to a low of 0.0 in Q3 2025.
- A 5-year average of 0.07 and a median of 0.02 in 2024 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio plunged 99.8% in 2023 and jumped 80618.2% in 2026, its largest moves.
- Tracing VTVT's Asset Utilization Ratio over 5 years: stood at 0.06 in 2022, then sank by 99.18% to 0.0 in 2023, then surged by 5083.04% to 0.02 in 2024, then slumped by 98.92% to 0.0 in 2025, then surged by 144520.54% to 0.39 in 2026.
- Business Quant data shows VTVT's Asset Utilization Ratio at 0.39 in Q1 2026, 0.0 in Q3 2025, and 0.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | 0.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.39 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.03 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.18 |
| Mar 31, 2022 | 0.22 |
| Dec 31, 2021 | 0.14 |
| Sep 30, 2021 | 0.39 |
| Jun 30, 2021 | 0.39 |
| Mar 31, 2021 | 0.47 |
| Dec 31, 2020 | 0.59 |